Xiaobai Li
- Nephrology top 10%
- Parathyroid Disorders and Treatments 3
-
- Pancreatic and Hepatic Oncology Research 3
-
- Renal cell carcinoma treatment 6
- Medical Imaging and Pathology Studies 3
-
- Childhood Cancer Survivors' Quality of Life 3
- Ethics and Legal Issues in Pediatric Healthcare 3
-
- Ethics in Clinical Research 3
-
- Augmented Reality Applications 2
- Co-authors
- Tanios Bekaii‐SaabMark M. ZalupskiBassel F. El‐RayesTodd M. BauerClelia PellicanoMary EhrmantrautAntonio GalloPhilip A. Philip
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Xiaobai Li
33 papers receiving 584 citations
Peers
Comparison fields: 5 of 89
- Nephrology 47
- Genetics 70
- Pathology and Forensic Medicine 109
- Oncology 142
- Psychiatry and Mental health 59
Countries citing papers authored by Xiaobai Li
This map shows the geographic impact of Xiaobai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobai Li more than expected).
Fields of papers citing papers by Xiaobai Li
This network shows the impact of papers produced by Xiaobai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobai Li. The network helps show where Xiaobai Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaobai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 14 | |
| 9 | 2021 | 3 | |
| 10 | 2021 | 6 | |
| 11 | 2020 | 55 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 1 | |
| 14 | 2015 | 14 | |
| 15 | 2012 | 91 | |
| 16 | 2012 | 20 | |
| 17 | 2010 | 120 | |
| 18 | 2010 | 6 | |
| 19 | 2010 | 5 | |
| 20 | 2009 | 18 |
About Xiaobai Li
Xiaobai Li is a scholar working on Nephrology, General Dentistry and Applied Microbiology and Biotechnology, having authored 33 papers that have together received 591 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (6 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Parathyroid Disorders and Treatments (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Medical Imaging and Pathology Studies (3 papers), Ethics in Clinical Research (3 papers), Ethics and Legal Issues in Pediatric Healthcare (3 papers) and Augmented Reality Applications (2 papers). The work is most often cited by research in Nephrology (47 citations), Genetics (70 citations) and Pathology and Forensic Medicine (109 citations). Xiaobai Li has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Tanios Bekaii‐Saab, Mark M. Zalupski, Bassel F. El‐Rayes, Todd M. Bauer, Clelia Pellicano, Mary Ehrmantraut, Antonio Gallo, Philip A. Philip, Henry F. McFarland and Vasiliki N. Ikonomidou. Their work appears in journals such as PLoS ONE, PEDIATRICS and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.